Nuclear Medicine/Radiopharmaceuticals Market
- Global Industry Analysis, Size, Share, Growth,
Trends and Forecast 2015 - 2023
Single User License:
Transparency Market Research
90, State Street, Suite 700.
Albany, NY 12207
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
Report will be delivered with in 15-20 working days
Nuclear medicines are the the drugs containing radioactive material (radionuclide-emmitting ionizing radiations)for the diagnosis and treatmentof
various diseases. Radiopharmaceuticals targetsthe organ or specific site and emitsthe gamma radiations which are captured by external gamma
cameras. However, dose of radiations is kept low to avoid the side effects. These radiopharmaceuticals are administered inside the body by
different routes of administration such as oral, inhalation or injection depending on the drug and targeted organ. Radiopharmaceuticals posses the
ability to diagnose the blood flow of brain cells, heart pumping rate and working mechanism of kidney cells. Radiopharmaceuticals also enables
the detection of Parkinson’s disease, Alzheimer’s, cancer location, tiny bone fractures, and functioning of transplanted organ.
Browse Full Report With TOC:- http://www.transparencymarketresearch.com/nuclear-medicine-radiopharmaceuticals-market.html
Global market of nuclear medicine/ radiopharmaceuticals can be segmented based on the product type, and applications. Product type might be
further classified into diagnostic and therapeutics products. Diagnostics products market could be further analyzed based on SPECT and PET
isotopes. Whereas, therapeutics market is divided into alpha emitters, beta emmiters, and brachytherapy. According to the World Nuclear